White Guide and Orange Guide Formatting Project - Pfizer

Referencing Quality Programs During Formulary Discussions
Orange Guide – Chapter 14: CGC Tools and Resources
Q. If a Managed Care Organization’s formulary decision maker asks me for
additional reasons why a Pfizer product should be included on its formulary,
may I discuss the quality and variety of our Quality Programs?
A. No. A Quality Program may never be offered as a reason for including a Pfizer
product on formulary. The quality program may be perceived as an item of
value offered to increase prescribing in violation of the anti-kickback laws.
Consequently, you must never affirmatively discuss a Quality Program in
relation to a formulary decision. If a customer makes an unsolicited inquiry
about the availability of Quality Programs, you may address it by:
FOR MORE INFORMATION
Stating that at the conclusion of your product discussion you can provide
information about the Quality Programs that Pfizer makes available to
its customers; and
Stating that an offer or provision of a Quality Program to the customer is
in no way influenced by the customer’s pending formulary decision.
Consult the CGC intranet site at http://mmweb2.pfizer.com for information and guidance on
CGC Tools and Resources, as well as a listing of available Quality Programs.
Questions may be referred to your manager, the Customer Marketing Group, your Regional
Attorney or CGC Legal Team.
226
Rev. 09/12
Page 7 of 7